CRYO CELL INTERNATIONAL INC
CRYO CELL INTERNATIONAL INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | |||||
Marketable Securities Current | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | |||||
Accounts Receivable Net Current | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | |||||
Prepaid Expense Current | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Inventory Net | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Assets Current | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Derivative Fair Value Of Derivative Asset | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 11 | 11 | 12 | 12 | 13 | 13 | 13 | 11 | 10 | 9 | 9 | 10 | |||||
Property Plant And Equipment Net | 21 | 21 | 21 | 21 | 21 | 22 | 22 | 22 | 22 | 22 | 21 | 19 | |||||
Long Term Investments And… | |||||||||||||||||
Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Inventory Noncurrent | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 9 | |||||
Goodwill | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Deferred Income Tax Assets Net | 24 | 24 | 24 | 21 | 21 | 21 | 21 | 20 | 20 | 20 | 20 | 14 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Assets Noncurrent | 29 | 29 | 29 | 30 | 30 | 30 | 30 | 30 | 30 | 31 | 31 | 41 | |||||
Assets | 61 | 61 | 62 | 63 | 64 | 64 | 65 | 63 | 63 | 62 | 61 | 70 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | |||||
Accrued Liabilities Current | 3 | 3 | 4 | 2 | 3 | 4 | 6 | 3 | 3 | 4 | 5 | 2 | |||||
Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Lines Of Credit Current | 0 | 2 | 2 | 3 | 7 | 5 | 4 | 2 | 4 | 2 | 1 | 3 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Contract With Customer Liability Current | 9 | 9 | 10 | 10 | 10 | 9 | 10 | 10 | 10 | 9 | 10 | 10 | |||||
Liabilities Current | 16 | 18 | 20 | 18 | 22 | 22 | 22 | 17 | 19 | 19 | 21 | 19 | |||||
Liabilities Noncurrent | |||||||||||||||||
Contract With Customer Liability Noncurrent | 53 | 52 | 51 | 50 | 49 | 48 | 47 | 45 | 44 | 43 | 41 | 40 | |||||
Long Term Notes Payable | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Long Term Debt Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Other Sundry Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 63 | 62 | 61 | 60 | 58 | 57 | 56 | 55 | 54 | 53 | 51 | 51 | |||||
Liabilities | 78 | 79 | 80 | 78 | 80 | 79 | 78 | 72 | 73 | 72 | 72 | 70 | |||||
Commitments And Contingencies | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 45 | 45 | 45 | 45 | 45 | 45 | 44 | 44 | 44 | 44 | 43 | 43 | |||||
Treasury Stock Value | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -24 | -23 | -23 | |||||
Retained Earnings Accumulated Deficit | -38 | -38 | -38 | -35 | -35 | -35 | -33 | -29 | -30 | -31 | -31 | -20 | |||||
Stockholders Equity | -18 | -18 | -19 | -15 | -16 | -15 | -13 | -10 | -11 | -10 | -11 | -0 | |||||
Liabilities And Stockholders Equity | 61 | 61 | 62 | 63 | 64 | 64 | 65 | 63 | 63 | 62 | 61 | 70 | |||||
Allowance For Doubtful Accounts Receivable Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Common Stock Shares Issued | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | |||||
Shares Outstanding | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.99% | -4.63% | -8.99% | - | - | - | - | - | - | - | - | - |
| 2025 | -9.34% | -4.08% | -6.66% | -0.20% | -7.33% | -7.54% | -7.69% | -12.31% | -24.62% | -8.24% | 1.18% | 6.47% |
| 2024 | 25.71% | 30.23% | 10.59% | -1.69% | -5.20% | -10.67% | 49.49% | 55.13% | 34.33% | -16.71% | -26.33% | -36.58% |
| 2023 | - | - | - | - | - | - | 0.60% | 15.87% | 14.09% | 26.93% | 48.51% | 78.22% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.71 | 0.62 | 0.59 | 0.63 | 0.60 | 0.58 | 0.58 | 0.61 | 0.52 | 0.49 | 0.45 | 0.54 | |||||
| Quick Ratio | 0.66 | 0.58 | 0.54 | 0.56 | 0.54 | 0.51 | 0.52 | 0.54 | 0.45 | 0.42 | 0.39 | 0.44 | |||||
| Working Capital | -4.63M | -6.69M | -8.03M | -6.78M | -8.70M | -9.21M | -9.04M | -6.76M | -9.29M | -9.92M | -11.41M | -8.63M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -4.42 | -4.31 | -4.32 | -5.26 | -5.14 | -5.39 | -5.89 | -7.58 | -6.82 | -6.97 | -6.55 | -4,319.28 | |||||
| Interest Coverage TTM | -0.05 | 0.09 | 0.23 | 1.86 | 1.64 | 1.77 | 1.87 | -9.76 | -10.46 | -9.64 | -7.81 | 2.16 | |||||
| Debt Ratio | 1.29 | 1.30 | 1.30 | 1.23 | 1.24 | 1.23 | 1.20 | 1.15 | 1.17 | 1.17 | 1.18 | 1.00 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.51 | 0.51 | 0.48 | 0.48 | 0.49 | 0.50 | 0.46 | |||||
| Days Sales Outstanding TTM | 81.15 | 81.84 | 81.84 | 78.79 | 78.52 | 79.24 | 79.22 | 76.30 | 77.94 | 77.08 | 73.48 | 68.86 | |||||
| Receivables Turnover TTM | 4.50 | 4.46 | 4.46 | 4.63 | 4.65 | 4.61 | 4.61 | 4.78 | 4.68 | 4.74 | 4.97 | 5.30 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.31 | -0.33 | -0.30 | -0.06 | -0.02 | 0.02 | 0.05 | -1.09 | -1.13 | -1.17 | -1.14 | 0.30 | |||||
| Free Cash Flow Per Share TTM | 0.76 | 0.61 | 0.65 | 0.77 | 0.73 | 0.66 | 0.44 | 0.38 | -0.06 | -0.00 | 0.25 | 0.34 | |||||
| Dividend Per Share TTM | 0.25 | 0.35 | 0.60 | 0.60 | 0.60 | 0.50 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 77.93% | 77.47% | 76.63% | 76.78% | 75.94% | 75.50% | 75.15% | 74.12% | 73.86% | 73.26% | 73.23% | 72.77% | |||||
| Operating Profit Margin TTM | -0.33% | 0.61% | 1.53% | 13.63% | 11.93% | 11.57% | 10.88% | -39.49% | -40.46% | -41.97% | -39.26% | 13.70% | |||||
| Net Profit Margin TTM | -7.92% | -8.52% | -7.70% | -1.49% | -0.54% | 0.40% | 1.26% | -28.04% | -29.38% | -31.02% | -30.38% | 8.02% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -2.69% | -2.56% | -1.31% | -0.29% | 1.10% | 2.33% | 2.05% | 1.95% | 1.93% | 1.52% | 3.32% | 4.49% | |||||
| Net Income Growth (1Y) | 1,339.81% | -2,170.66% | -704.18% | -94.69% | -98.16% | -101.32% | -104.22% | -456.17% | -505.57% | -459.63% | -443.57% | 93.32% | |||||
| EPS Growth (1Y) | 1,344.22% | -2,177.61% | -708.82% | -94.69% | -98.15% | -101.35% | -104.33% | -466.10% | -515.94% | -467.85% | -448.71% | 95.74% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -11.01 | -10.28 | -14.28 | -79.97 | -241.51 | 481.87 | 164.90 | -5.12 | -6.56 | -4.04 | -4.28 | 18.13 | |||||
| P/B TTM | -1.53 | -1.49 | -1.86 | -2.55 | -2.66 | -4.23 | -5.02 | -4.78 | -5.68 | -3.80 | -3.70 | -2,810.53 | |||||
| P/S TTM | 0.87 | 0.88 | 1.10 | 1.19 | 1.29 | 1.93 | 2.07 | 1.43 | 1.93 | 1.25 | 1.30 | 1.45 | |||||
| Market Cap | 27.15M | 27.39M | 34.70M | 37.87M | 41.37M | 62.02M | 66.31M | 45.67M | 60.96M | 39.33M | 40.77M | 45.43M | |||||
| Enterprise Value | 34.92M | 37.06M | 45.03M | 49.19M | 56.27M | 74.82M | 77.74M | 56.20M | 73.25M | 49.61M | 50.18M | 56.20M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 6.11M | 4.94M | 5.25M | 6.18M | 5.94M | 5.31M | 3.61M | 3.09M | -512.24K | -2.13K | 2.08M | 2.86M | |||||
| Net Debt | 7.77M | 9.67M | 10.33M | 11.32M | 14.90M | 12.80M | 11.44M | 10.53M | 12.28M | 10.29M | 9.41M | 10.77M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
CRYO CELL INTERNATIONAL INC (CCEL) — SEC Financial Statements & Analysis
CRYO CELL INTERNATIONAL INC (CCEL) is a services-misc health & allied services, nec company, incorporated in DE. CRYO CELL INTERNATIONAL INC trades on NYSE as: CCEL. Based on its latest SEC filing (Form 10-Q, period ending 2026-05-31), CRYO CELL INTERNATIONAL INC reported a -2.69% year-over-year revenue growth, a Gross Profit Margin of 77.93% (TTM), a Debt-to-Equity ratio of -4.42x, a Price-to-Sales (P/S) ratio of 0.87x (TTM), a Price-to-Book (P/B) ratio of -1.53 (TTM), at a market cap of $27.15M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -2.69%
- Gross Profit Margin TTM
- 77.93%
- Debt To Equity
- -4.42x
- P/S TTM
- 0.87x
- P/B TTM
- -1.53
- Market Cap
- $27.15M
Data as of 2026-05-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CRYO CELL INTERNATIONAL INC in?
CRYO CELL INTERNATIONAL INC (CCEL) operates in the Services-Misc Health & Allied Services, NEC industry.
What is CCEL's market cap?
CRYO CELL INTERNATIONAL INC (CCEL) has a market capitalization of $27.15M as of 2026-05-31.
What exchange does CCEL trade on?
CRYO CELL INTERNATIONAL INC (CCEL) trades on the NYSE.
Where is CRYO CELL INTERNATIONAL INC incorporated?
CRYO CELL INTERNATIONAL INC is incorporated in DE.